NCT07020117 2026-04-21A Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsAktis Oncology, Inc.Phase 1 Recruiting150 enrolled
NCT03831932 2026-04-13Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 1/2 Active not recruiting22 enrolled 12 charts
NCT06982222 2026-04-13Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to BonesNational Cancer Institute (NCI)Phase 1 Not yet recruiting24 enrolled